Education
About Us
Working with TipRanks
Follow Us
FGM - ETF AI Analysis
Top Page
First Trust Germany AlphaDEX Fund (FGM)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past three months and year-to-date, indicating positive recent momentum.
Leading Holdings Performing Well
Several of the largest positions, such as Schaeffler, Aurubis, Bayer, and thyssenkrupp, have delivered strong year-to-date returns that support the fund’s overall performance.
Diversified Sector Exposure Within Germany
Holdings spread across industrials, consumer cyclical, materials, real estate, financials, health care, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Country Concentration in Germany
With the vast majority of assets invested in German companies, the fund is heavily exposed to economic and market conditions in Germany.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Notable Weakness in Some Top Holdings
A few major positions, including Aroundtown, BMW, and LEG Immobilien, have shown weak or negative year-to-date performance, which can drag on the fund if the trend continues.
FGM vs. SPDR S&P 500 ETF (SPY)
AUM119.26M
RegionEurope
Expense Ratio0.80%
Beta0.78
IssuerFirst Trust
Inception DateFeb 14, 2012
Dividend Yield0.67%
Asset ClassEquity
Index TrackedNASDAQ AlphaDEX Germany Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume24,994
30 Day Avg. Volume19,436
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
72.14Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering40
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FGM Summary
FGM is an exchange-traded fund that follows the NASDAQ AlphaDEX Germany Index, focusing mainly on German stocks. It uses a rules-based strategy to pick companies it believes have strong growth or good value, rather than just buying the biggest firms. The fund holds well-known German names like Bayer and BMW, along with many industrial and consumer-focused companies. An investor might consider FGM to diversify into Germany, one of Europe’s largest economies, and to seek long-term growth outside the U.S. A key risk is that it is heavily tied to the German stock market, so its value can rise and fall sharply with that market.
How much will it cost me?The First Trust Germany AlphaDEX Fund (FGM) has an expense ratio of 0.8%, meaning you’ll pay $8 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized stock selection strategy to try to outperform traditional indices.
What would affect this ETF?The First Trust Germany AlphaDEX Fund (FGM) could benefit from Germany's strong industrial sector and innovation-driven economy, especially if global demand for industrial and consumer goods remains high. However, challenges like rising interest rates in Europe, economic slowdowns, or regulatory changes affecting key sectors such as financials and utilities could negatively impact the ETF's performance. Investors should also consider how geopolitical tensions or shifts in trade policies might influence Germany's export-driven economy.
FGM Top 10 Holdings
FGM is essentially a bet on Germany’s industrial engine, with names like Aurubis, Hochtief, Bilfinger, and thyssenkrupp doing much of the heavy lifting as they trend higher on improving momentum and solid fundamentals. Real estate players such as Aroundtown and LEG Immobilien add a twist: they’ve shown improving or mixed performance, helping when sentiment is constructive but adding some bumpiness. BMW and Bayer are more of a mixed bag, occasionally losing steam and tempering gains. Overall, this is a Germany-only play, tilted toward cyclical, industrial strength.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Aurubis | 5.54% | $6.49M | €6.99B | 77.38% | 74 Outperform | |
| Nordex | 4.83% | $5.66M | €9.71B | 185.70% | 71 Outperform | |
| Hochtief | 4.72% | $5.53M | €27.86B | 131.61% | 69 Neutral | |
| LEG Immobilien | 4.25% | $4.98M | €4.74B | -9.39% | 70 Outperform | |
| Bilfinger | 4.07% | $4.76M | €3.81B | 51.84% | 74 Outperform | |
| Aroundtown SA | 4.00% | $4.68M | €2.72B | 4.93% | 59 Neutral | |
| Deutsche Lufthansa | 3.87% | $4.54M | €9.12B | -2.42% | 76 Outperform | |
| Schaeffler | 3.74% | $4.38M | €6.89B | 68.05% | 52 Neutral | |
| Bayerische Motoren Werke Aktiengesellschaft | 3.64% | $4.27M | $54.33B | -2.22% | 71 Outperform | |
| Bayer | 3.47% | $4.07M | €36.93B | 57.94% | 54 Neutral |
FGM Technical Analysis
Negative
―
Price Trends
66.39
Negative
62.71
Negative
59.66
Positive
Market Momentum
-1.24
Positive
30.56
Neutral
17.45
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FGM, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 67.21, equal to the 50-day MA of 66.39, and equal to the 200-day MA of 59.66, indicating a neutral trend. The MACD of -1.24 indicates Positive momentum. The RSI at 30.56 is Neutral, neither overbought nor oversold. The STOCH value of 17.45 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FGM.
FGM Peer Comparison
Comparison Results
Performance Comparison
FGM
First Trust Germany AlphaDEX Fund
62.18
14.43
30.22%
EWG
iShares MSCI Germany ETF
―
―
―
FLGB
Franklin FTSE United Kingdom ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
DAX
Global X DAX Germany ETF
―
―
―
FLGR
Franklin FTSE Germany ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents